PUBLISHED ON: December 23, 2016 | Duration: 10 min, 29 sec
Jay Thakkar, senior technical analyst at Sharekhan says that the dream run in pharma shares which started in 2012 has ended and most of the shares in this space are going through a phase of correction.
